HighMark Wealth Management LLC

Position in CRNX — Crinetics Pharmaceuticals, Inc.

CIK 1802451 ST. PAUL, MN

Position in CRNX

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$1,444,224

+$699,846 QoQ

Shares Held

38,595

+88.3% QoQ

Ownership

0.036%

of shares outstanding

% of Portfolio

1.35%

of 13F equity value

Holder Rank

#110

of 266 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

HighMark Wealth Management LLC holds $13,360,619 across 36 Biotechnology names. CRNX ranks #4 (10.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	APGE	Apogee Therapeutics, Inc.	32,266	$4,282,666
2	ANAB	Anaptysbio, Inc	39,716	$2,680,830
3	EWTX	Edgewise Therapeutics, Inc.	53,179	$2,160,662
4	CRNX	Crinetics Pharmaceuticals, Inc. This page	38,595	$1,444,224
5	XENE	Xenon Pharmaceuticals Inc.	23,000	$1,388,280
6	AUPH	Aurinia Pharmaceuticals Inc.	35,196	$597,276
7	MDXG	Mimedx Group, Inc.	55,878	$215,130
8	VKTX	Viking Therapeutics, Inc.	5,310	$207,143

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,444,224	38,595	+88.3%	Shares	Sole	2026-08-12
2026-03-31	$744,378	20,495	-4.7%	Shares	Sole	2026-05-06
2025-12-31	$1,000,592	21,495	+7.5%	Shares	Sole	2026-02-05
2025-09-30	$832,791	19,995	0.0%	Shares	Sole	2025-10-20
2025-06-30	$575,056	19,995	0.0%	Shares	Sole	2025-07-21
2025-03-31	$670,632	19,995	0.0%	Shares	Sole	2025-04-24
2024-12-31	$1,022,344	19,995	0.0%	Shares	Sole	2025-01-31
2024-09-30	$1,021,744	19,995	0.0%	Shares	Sole	2024-10-17
2024-06-30	$895,576	19,995	+16.1%	Shares	Sole	2024-07-29
2024-03-31	$805,834	17,215	+305.1%	Shares	Sole	2024-04-29
2023-12-31	$151,215	4,250	—	Shares	Sole	2024-01-23
No filing history on record for this holder in this stock.